Ludo Vanopdenbosch

3.0k total citations
50 papers, 1.2k citations indexed

About

Ludo Vanopdenbosch is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Ludo Vanopdenbosch has authored 50 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 18 papers in Neurology and 8 papers in Oncology. Recurrent topics in Ludo Vanopdenbosch's work include Multiple Sclerosis Research Studies (16 papers), Peripheral Neuropathies and Disorders (6 papers) and Polyomavirus and related diseases (6 papers). Ludo Vanopdenbosch is often cited by papers focused on Multiple Sclerosis Research Studies (16 papers), Peripheral Neuropathies and Disorders (6 papers) and Polyomavirus and related diseases (6 papers). Ludo Vanopdenbosch collaborates with scholars based in Belgium, United States and Germany. Ludo Vanopdenbosch's co-authors include Melissa Cambron, Miguel D’haeseleer, Jacques De Keyser, Stefaan J. Vandecasteele, Wim Robberecht, Ludo Van Den Bosch, Jean‐Jacques Martin, Joél Smet, Rudy Van Coster and Lindsey Van Haute and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Clinical Infectious Diseases.

In The Last Decade

Ludo Vanopdenbosch

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ludo Vanopdenbosch Belgium 14 450 388 246 156 152 50 1.2k
Antonios Bayas Germany 19 459 1.0× 224 0.6× 216 0.9× 98 0.6× 77 0.5× 52 1.2k
Gülay Alper United States 19 677 1.5× 729 1.9× 244 1.0× 56 0.4× 170 1.1× 33 1.4k
Hirofumi Ochi Japan 24 654 1.5× 468 1.2× 323 1.3× 119 0.8× 49 0.3× 89 1.8k
Panos Stathopoulos United States 22 290 0.6× 808 2.1× 167 0.7× 77 0.5× 240 1.6× 38 1.4k
Jonatan Salzer Sweden 21 1.6k 3.6× 638 1.6× 201 0.8× 118 0.8× 158 1.0× 49 2.1k
Begoña Oliver‐Martos Spain 17 262 0.6× 251 0.6× 229 0.9× 102 0.7× 108 0.7× 63 959
Sanjay C. Keswani United States 14 97 0.2× 272 0.7× 184 0.7× 142 0.9× 113 0.7× 30 1.1k
E. Merelli Italy 17 596 1.3× 430 1.1× 141 0.6× 56 0.4× 105 0.7× 51 1.2k
Amanda Cox United States 18 809 1.8× 470 1.2× 163 0.7× 70 0.4× 33 0.2× 45 1.8k
Carolina Ionete United States 16 495 1.1× 251 0.6× 491 2.0× 123 0.8× 70 0.5× 51 1.3k

Countries citing papers authored by Ludo Vanopdenbosch

Since Specialization
Citations

This map shows the geographic impact of Ludo Vanopdenbosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludo Vanopdenbosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludo Vanopdenbosch more than expected).

Fields of papers citing papers by Ludo Vanopdenbosch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludo Vanopdenbosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludo Vanopdenbosch. The network helps show where Ludo Vanopdenbosch may publish in the future.

Co-authorship network of co-authors of Ludo Vanopdenbosch

This figure shows the co-authorship network connecting the top 25 collaborators of Ludo Vanopdenbosch. A scholar is included among the top collaborators of Ludo Vanopdenbosch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludo Vanopdenbosch. Ludo Vanopdenbosch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hijfte, Liesbeth Van, Melissa Cambron, Ludo Vanopdenbosch, et al.. (2025). Multiple Sclerosis Nursing to Improve Care and Education (MSNICE): an observational study. BMC Nursing. 24(1). 94–94.
2.
Kesel, Pieter De, Melissa Cambron, Ludo Vanopdenbosch, et al.. (2024). Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis. Frontiers in Immunology. 15. 1385231–1385231. 4 indexed citations
3.
Hartung, H-P, Thomas Berger, Bruno Brochet, et al.. (2020). Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 46. 102492–102492. 22 indexed citations
4.
Ameele, Hans van den, et al.. (2019). [Neurosyphilis: a historical disease with current relevance].. PubMed. 61(10). 720–724. 1 indexed citations
5.
6.
Algoet, Michiel, et al.. (2019). Intracanal Optic Nerve Cavernous Hemangioma: A Case Report and Review of the Literature. World Neurosurgery. 126. 428–433. 8 indexed citations
7.
Smets, Ide, Cedric Bohyn, Vincent Van Pesch, et al.. (2017). Corticosteroids in the management of acute multiple sclerosis exacerbations. Acta Neurologica Belgica. 117(3). 623–633. 30 indexed citations
8.
Cadavid, Diego, Laura J. Balcer, Steven Galetta, et al.. (2017). Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. The Lancet Neurology. 16(3). 189–199. 197 indexed citations
9.
Vanopdenbosch, Ludo & David Oliver. (2015). Neurology and Palliative care: a barriers analysis. (P3.301). Neurology. 84(14_supplement). 1 indexed citations
10.
Cadavid, Diego, Laura J. Balcer, Steven Galetta, et al.. (2015). Efficacy Analysis of the Anti-LINGO-1 Monoclonal Antibody BIIB033 in Acute Optic Neuritis: the RENEW Trial (P7.202). Neurology. 84(14_supplement). 16 indexed citations
11.
Pelzer, Nadine, et al.. (2014). Are atraumatic spinal needles as efficient as traumatic needles for lumbar puncture?. Neurological Sciences. 35(12). 1997–1999. 3 indexed citations
12.
D’haeseleer, Miguel, Melissa Cambron, Ludo Vanopdenbosch, & Jacques De Keyser. (2011). Vascular aspects of multiple sclerosis. The Lancet Neurology. 10(7). 657–666. 185 indexed citations
13.
Vandecasteele, Stefaan J., et al.. (2011). Toxocariasis Presenting as Encephalomyelitis. Case Reports in Medicine. 2011. 1–4. 8 indexed citations
14.
Vanopdenbosch, Ludo, Peter Dedeken, J Casselman, & Stephan Vlaminck. (2010). MRI with intrathecal gadolinium to detect a CSF leak: a prospective open-label cohort study. Journal of Neurology Neurosurgery & Psychiatry. 82(4). 456–458. 29 indexed citations
15.
Ghekiere, Johan, et al.. (2007). Post-traumatic pulsatile tinnitus: the hallmark of a direct carotico-cavernous fistula. The Journal of Laryngology & Otology. 121(11). 1103–1107. 8 indexed citations
16.
Régal, Luc, Ludo Vanopdenbosch, Petra Tilkin, et al.. (2006). The G93C Mutation in Superoxide Dismutase 1. Archives of Neurology. 63(2). 262–262. 65 indexed citations
17.
Vriese, An S. De, Rudy Van Coster, Joél Smet, et al.. (2006). Linezolid-Induced Inhibition of Mitochondrial Protein Synthesis. Clinical Infectious Diseases. 42(8). 1111–1117. 216 indexed citations
18.
Vanopdenbosch, Ludo, et al.. (2000). Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis. Journal of Neurology. 247(7). 535–543. 49 indexed citations
19.
Vanopdenbosch, Ludo, et al.. (1998). Leão's Cortical Spreading Depression and the Somatosensory Homunculus: A Contradiction?. Headache The Journal of Head and Face Pain. 38(4). 322–323. 1 indexed citations
20.
Dequeker, J., et al.. (1995). Early evidence of scleroderma. BMJ. 311(7021). 1714–1715. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonios Bayas Breakdown of academic impact, for papers by Gülay Alper Breakdown of academic impact, for papers by Hirofumi Ochi Breakdown of academic impact, for papers by Panos Stathopoulos Breakdown of academic impact, for papers by Jonatan Salzer Breakdown of academic impact, for papers by Begoña Oliver‐Martos Breakdown of academic impact, for papers by Sanjay C. Keswani Breakdown of academic impact, for papers by E. Merelli Breakdown of academic impact, for papers by Amanda Cox Breakdown of academic impact, for papers by Carolina Ionete
Rankless by CCL
2026